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bDepartment of Radiology, Medical University of Vienna, Vienna, AustriaAbstractPurpose: The purpose of this study was to evaluate the sensitivity of a direct computer-aided detection (CAD) system (d-CAD) in full-field
digital mammography (FFDM) for the detection of microcalcifications not associated with mass or architectural distortion.
Materials and Methods: A database search of 1063 consecutive stereotactic core biopsies performed between 2002 and 2005 identified 196
patients with Breast Imaging-Reporting andData System (BI-RADS) 4 and 5microcalcifications not associated with mass or distortion detected
exclusively by bilateral FFDM. A commercially available CAD system (Second Look, version 7.2) was retrospectively applied to the cranio-
caudal and mediolateral oblique views in these patients (mean age, 59 years; range, 35e84 years). Breast density, location and mammographic
size of the lesion, distribution, and tumour histology were recorded and analysed by using c2, Fisher exact, or McNemar tests, when applicable.
Results:Whenusing d-CAD, 71 of 74malignantmicrocalcification cases (96%) and101of 122 benignmicrocalcifications (83%)were identified.
There was a significant difference (P < .05) between CAD sensitivity on the craniocaudal view, 91% (68 of 75), vs CAD sensitivity on the
mediolateral oblique view, 80% (60 of 75). The d-CAD sensitivity for dense breast tissue (American College of Radiology [ACR] density 3 and 4)
was higher (97%) than d-CAD sensitivity (95%) for nondense tissue (ACR density 1 and 2), but the differencewas not statically significant. All 28
malignant calcifications larger than 10 mm were detected by CAD, whereas the sensitivity for lesions small than or equal to 10 mm was 94%.
Conclusions: D-CAD had a high sensitivity in the depiction of asymptomatic breast cancers, which were seen as microcalcifications on
FFDM screening, with a sensitivity of d-CAD on the craniocaudal view being significantly better. All malignant microcalcifications larger
than 10 mm were detected by d-CAD.Re´sume´Objet: Cette e´tude avait pour objet d’e´valuer la sensibilite´ d’un syste`me direct de de´tection assiste´e par ordinateur utilise´ en mammographie
nume´rique plein champ pour de´tecter les microcalcifications non associe´es a` la pre´sence de masses ou a` une distorsion architecturale.
Mate´riel et me´thodes: Une recherche dans une base de donne´es re´pertoriant 1 063 microbiopsies ste´re´otaxiques conse´cutives pratique´es
entre 2002 et 2005 a permis d’identifier 196 patientes pre´sentant des microcalcifications de type BI-RADS 4 et 5 non associe´es a` la pre´sence
de masses ou a` une distorsion architecturale de´tecte´es exclusivement au moyen de la mammographie nume´rique plein champ bilate´rale. Un
syste`me de de´tection assiste´e par ordinateur offert sur le marche´ (Second Look, version 7.2) a e´te´ applique´ re´trospectivement aux incidences
cranio-caudales et me´dio-late´rales obliques de ces patientes (aˆge moyen de 59 ans; fourchette de 35 a` 84 ans). La densite´ mammaire,
l’emplacement et la taille mammographique de la le´sion, la re´partition et l’histologie de la tumeur ont e´te´ consigne´s et analyse´s au moyen du
c2, de la me´thode exacte de Fisher ou du test McNemar, selon le cas.
Re´sultats: L’utilisation du syste`me direct de de´tection assiste´e par ordinateur a permis de de´tecter 71 cas de microcalcifications malignes sur
74 (96 %) et 101 cas de microcalcifications be´nignes sur 122 (83 %). Il y avait une diffe´rence significative (P < 0,05) entre la sensibilite´ de la
de´tection assiste´e par ordinateur par l’analyse des incidences cranio-caudales, soit 91 % (68 sur 75), par opposition a` sa sensibilite´ par
l’analyse des incidences me´dio-late´rales obliques, soit 80 % (60 sur 75). La sensibilite´ du syste`me direct de de´tection assiste´e par ordinateur* Address for correspondence: Anabel M. Scaranelo, MD, Department of
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163D-CAD FFDM of microcalcifications / Canadian Association of Radiologists Journal 61 (2010) 162e169e´tait plus e´leve´e (97 %) par l’analyse de tissus mammaires denses (densite´ de 3 et 4 selon l’ACR) que par l’analyse de tissus mammaires non
denses (densite´ de 1 et 2 selon l’ACR) (95 %), mais cette diffe´rence n’e´tait pas statistiquement significative. Le syste`me de de´tection assiste´e
par ordinateur a de´tecte´ les 28 calcifications malignes d’une taille supe´rieure a` 10 mm et a affiche´ un taux de sensibilite´ de 94 % a` l’e´gard des
le´sions d’une taille infe´rieure ou e´gale a` 10 mm.
Conclusions: Le syste`me direct de de´tection assiste´e par ordinateur e´tait tre`s sensible lorsqu’il s’agissait de de´montrer les cancers du sein
asymptomatiques, qui apparaissaient sous la forme de microcalcifications lors du de´pistage par mammographie nume´rique plein champ. Sa
sensibilite´ e´tait plus e´leve´e par l’analyse des incidences cranio-caudales. Le syste`me de de´tection assiste´e par ordinateur a de´tecte´ toutes les
microcalcifications malignes d’une taille supe´rieure a` 10 mm.
 2010 Canadian Association of Radiologists. All rights reserved.
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promise for clinical advancement. Since its approval by the
U.S. Food and Drug Administration (FDA) in June 1998 for
the first commercial use, computer-aided detection (CAD)
software in mammography has become increasingly avail-
able worldwide. CAD is designed to provide visual prompts
in specific areas on the image. The image needs to be in
digital media presentation for the interpreting radiologist,
either by digitizing analog mammograms or by using digital
mammography systems (direct radiography [DR] or
computed radiography [CR]).
Much of the clinical research that evaluated CAD in
mammography was based on digitized film-screen
mammograms, which is also called indirect CAD [1e16].
For indirect CAD, the reported sensitivity is 76% for masses
(49%e90%) and 90% for calcifications (40%e100%). Little
has been published [17e23] about the accuracy of CAD
applied to digital mammography, called direct CAD (d-
CAD). One of the FDA’s approved devices (ImageChecker;
R2 Technology, Los Altos, CA) has a reported sensitivity of
79% for masses and 90% for calcifications [1e4,9,10,17e
22] and the other major FDA-approved device (Second Look
System, iCAD, Nashua, NH) has a reported sensitivity of
92% for masses and 93% for calcifications [23]. The purpose
of our study was to retrospectively evaluate the sensitivity of
a d-CAD system in depicting pure microcalcification or areas
of microcalcifications without associated density, mass, or
architectural distortion depicted on bilateral full-field digital
mammography (FFDM) that proved to be malignant at
subsequent surgery.
Materials and MethodsPatientsInstitutional research ethics board approval was obtained.
The study was compliant with the Health Insurance Porta-
bility and Accountability Act. Chart review was performed
for all patients who underwent stereotactic core biopsy
between 2002 and 2005 at a tertiary hospital. Patients
referred for biopsy with Breast Imaging-Reporting and Data
System (BI-RADS) 4 and 5 calcifications detected by routine
screening FFDM were included in the study population.Patients ranged in age from 35–84 years (mean age, 59
years), and those younger than 40 years had screening
mammography because they were high-risk patients. A total
of 1063 patients underwent stereotactic biopsies; of these,
243 had screening mammogram performed on a FFDM
(Senographe 2000D; GE Medical Systems, Milwaukee, WI).
Of 243 cases, 39 had to be excluded because of technical
factors (in 35 patients, the most recent d-CAD version could
not be retrospectively applied, and 4 cases had only magni-
fication views done on FFDM). Eight cases were excluded
because of the association with a mass. Of the remaining 196
patients, 193 had excision biopsy. Three patients refused
surgical excision and opted out for mammographic follow-
up. Our study population was made up diagnosis of 74 cases
of breast cancer (21 invasive and 53 in situ carcinomas) and
122 benign calcifications on surgical excision or with a mean
4.17 years imaging follow-up. The mean (standard deviation)
age of the 196 women was 57.23  8.47 years.Digital Mammography and d-CADAll digital mammograms were obtained by using a FFDM
unit (Senographe 2000D). All mammograms (craniocaudal
[CC] and mediolateral oblique [MLO] views) were reviewed
by using a dedicated workstation (Advantage GE Worksta-
tion; GE Medical Systems), which runs with a d-CAD
system (Second Look System, version 7.2; iCAD, Nashua,
NH). The d-CAD system marks areas of concern, such as
calcifications, masses, and architectural distortion.Images ReviewA soft-copy review was performed in a dedicated dark-
ened room for digital mammography by a single radiologist
(A.M.S., with 13 years of postebreast imaging fellowship
experience and 5 years of experience with soft-copy reading)
who used the Advantage GE Workstation, which included 2
high-resolution 2,000  2,500-pixel monitors and a dedi-
cated keypad. This single radiologist recorded the location
(quadrant and subareolar), distribution (clustered, segmental,
linear, and regional), and the density of the breast (American
College of Radiology [ACR] density 3 or heterogeneously
dense, and ACR density 4 or extremely dense were
Table 1
Case-based performance of direct CAD system for mammographic views: MLO, CC, and in at least 1 view
MLO view CC view At least 1 view
CAD marksa
Sensitivity/
specificity, % CAD marksa
Sensitivity/
specificity, % CAD marksa
Sensitivity/
specificity, %
Dense M; dense B 35 of 38; 38 of 62 92/39 36 of 38; 42 of 62 95/32 37 of 38; 53 of 62 97/15
Nondense M; nondense B 25 of 36; 42 of 60 72/30 30 of 36; 32 of 60 83/47 34 of 36; 49 of 60 94/18
All M; all B 60 of 74; 80 of 122 81/34 66 of 74; 74 of 122 89/39 71 of 74; 102 of 122 96/16
aTable data are the number of microcalcification lesions marked by CAD of the number of calcification lesions in the category.
CAD ¼ computer-aided detection system; MLO ¼ mediolateral; CC ¼ craniocaudal; M ¼ malignant calcification; B ¼ benign calcification.
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density 2 or scattered fibroglandular tissue were categorized
as nondense for statistical analysis). Postprocessing of the
images (window-level adjustments, zooming, and inversion)
were available. The mammographic lesion size (in millime-
ters) was considered as the largest mammographically visible
dimension of the detected area of microcalcifications in 1 of
the standard mammographic projections by 2 experienced
radiologists (P.C. and A.M.S.) in consensus. For statistical
analysis, the maximum extensions of the area of micro-
calcifications were divided into 2 groups: group 1, diameter
smaller than 10 mm (145 cases); group 2, diameter larger
than 10 mm (51 cases). The radiologists knew the location of
the diagnosed cancer while reviewing the mammograms with
d-CAD prompts marking potential areas of concerns. The
precise location of the area of microcalcifications was
determined on both CC and MLO views on the screen
monitor. This geographic position of the display was
compared with the location marked by the d-CAD system to
determine whether the calcifications on each view were
correctly identified by the system and whether geographic
position corresponded to the biopsy sampled area. If the d-
CAD system marked the mammographic location of the
cancer in at least 1 view, then the case was considered true
positive. Carcinomas not marked were considered false
negative. Sensitivities of the d-CAD system were calculated
in 3 ways: (1) sensitivity was calculated for in at least 1 view;
(2) by using a subset group considering only marks depicted
in the MLO view; and (3) by considering d-CAD marks only
in the CC view.Statistical AnalysisThe potential predictor variables of density of the breast
(dense, heterogeneously dense, scattered fibroglandular, or
fatty), mammographic lesion size (in millimeters), distribu-
tion of the lesion, and tumour histology (invasive or in situ)
were compared with the findings in each view (CC or MLO).
Statistics with 95% confidence intervals based on asymptotic
standard errors were computed to assess the agreement rate
between the d-CAD readings of the 2 views. These variables
were first analysed to help determine if they met the distri-
butional assumptions of the statistical tests that were being
used to analyse them. On the basis of these preliminary
numeric and graphic techniques, parametric, nonparametric,
or exact statistical tests were used to analyse the data.Continuous variables were described by using means, stan-
dard deviations, medians, minimums, and maximums.
Categoric variables were described by using frequencies and
row and column percentages.
Contingency tables were analysed by using the c2 test or
the Fisher exact test. Because the marking of micro-
calcifications is performed separately by the d-CAD system,
all statistical analyses were done separately for MLO and CC
views, and the combination of them. Sensitivity and the
corresponding 95% confidence intervals were computed for
each view. The McNemar test was used to assess the
significance of the agreement rate between the d-CAD
reading of the 2 views. A P value less than .05 (probability of
type I error) was considered to indicate a significant differ-
ence throughout this study. All analyses were conducted by
using SAS software for Windows (version 8.2; SAS Institute,
Cary, NC).ResultsD-CAD MarksOf the 74 malignant calcifications, 71 (96%) were marked
by the d-CAD system on at least 1 view, 55 (74%) were
marked by the d-CAD on both of the 2 views. Three (4%)
were not marked on any view, 11 (14%) were marked on the
CC view only, and 5 (6%) were marked on the MLO view
only. Of the 122 benign calcifications evaluated with the
d-CAD system, the false-positive marks per image averaged
1.25 per patient for both the 2 views and were 0.59 per image
for the CC view and 0.65 per image for the MLO view; these
differences were not significant (P > .1).SensitivitiesThe case-based sensitivity of the d-CAD system is
summarized in Table 1. The sensitivity of d-CAD in marking
calcifications associated with breast carcinomas on at least 1
view was 96% (71 of 74). The sensitivity was 89% (66 of 74)
in the CC view and 81% (60 of 74) in the MLO view. The
difference in the sensitivity of d-CAD between the MLO
view and in at least 1 view was statistically significant (P ¼
.003). The d-CAD sensitivity in at least one view was higher
than in the MLO view and this was found statistically
significant (P = .003).
Table 2
Performance of direct-CAD sensitivity by malignant microcalcification size with mammographic views
Largest dimension measured in full-field digital mammography MLO view CC view At least 1 view
CAD marksa Sensitivity, % CAD marksa Sensitivity, % CAD marksa Sensitivity, %
<10 mm 35 of 46 76 38 of 46 83 43 of 46 93
10 mm 25 of 28 89 28 of 28 100 28 of 28 100
All (n ¼ 74) 60 of 74 81 66 of 74 89 71 of 74 96
aTable data are the number of microcalcification lesions marked by CAD of the number of calcification lesions in the category.
CAD ¼ computer-aided detection system; MLO ¼ mediolateral oblique; CC ¼ craniocaudal.
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(range, 2e57 mm) along its longest axis. Of a total of 74
lesions, 46 (62%) were in the right breast and 28 (38%) were
in the left. Twenty-seven of 74 cancers (36%) were in the
upper outer quadrant, 7 (9%) were in the upper inner quad-
rant, 6 (8%) were in the lower outer quadrant, 4 (5%) were in
the lower inner quadrant, 10 (13%) were in the 12-o’clock
position, 4 (5%) were in the 9-o’clock position, 8 (11%) were
in the 6-o’clock position, 3 (4%) were in the 3-o’clock
position, and 5 (6%) were in the central or subareolar posi-
tion. Thirty (41%) of the 74 breasts were of scattered
fibroglandular tissue, 32 (43%) were heterogeneously dense,
5 (7%) were fatty, and 7 (9%) were extremely dense. There
was no difference (P > .1) in d-CAD sensitivity in the
nondense breast tissue (94% [34/36]) vs d-CAD sensitivity in
the dense breast tissue (97% [37/38]). Sensitivity of the
d-CAD system as related to lesion size is shown in Table 2.
Three of 46 lesions smaller than 10 mm were not marked by
d-CAD. All other 28 lesions (100%) with a size equal or
larger than 10 mm were marked by d-CAD in the CC view
(P ¼ .01). There was no difference (P > .1) in d-CAD
sensitivity with respect to the distribution of the calcifica-
tions (Table 3).Calcifications and HistologyTwenty-one of 74 lesions (28%) had an invasive component
at surgical excision, 39 (53%) had in situ carcinomawith a high
nuclear grade (grade 3/3), and 14 (19%) had a final diagnosis of
low-to-intermediateegrade in situ carcinoma. The d-CAD
systemdid not identify 3 cancers, 2 invasive (9.5%) and 1 in situ
(4%), on either views, 6 of 53 in situ carcinomas (11%) and 3 of
21 invasive carcinomas (14%) were not identified on CC viewTable 3
Sensitivity of CAD system for malignant microcalcifications as related to
calcification distribution
Calcification
distribution
Mediolateral oblique
view, % (no.)
Craniocaudal
view, % (no.)
At least 1 view,
% (no.)
Clustered (n ¼ 47) 79 (37 of 47) 85 (40 of 47) 96 (45 of 47)
Segmental (n ¼ 12) 92 (11 of 12) 100 (12 of 12) 100 (12 of 12)
Linear (n ¼ 14) 86 (12 of 14) 93 (13 of 14) 93 (13 of 14)
Regional (n ¼ 1) 0 100 (1 of 1) 100 (1 of 1)
All (n ¼ 74) 81 (60 of 74) 89 (66 of 74) 96 (71 of 74)and 9 of 53 in situ carcinomas (17%) and 5 of 21 invasive
carcinomas (24%) not identified onMLOview.Of the 3 cancers
not marked by d-CAD on either MLO or CC views, 2 were
clusters of indeterminate microcalcifications, 1 measured 0.3
cm in the lower hemispheres of the left breast (6 o’clock posi-
tion) and the second onewas 0.4 cm in the upper outer quadrant
of the right breast, both invasive on histopathology.The third
cancer was seen as a 9-mm linear branching microcalcification
in the lower outer quadrant of the left breast; it was found as
a 2.5-mm high-grade in situ carcinoma cribriform architecture
andprominentmicrocalcification associatedwith columnar cell
changes and benign lobules (Figure 1). The sensitivity of
d-CADfor detectionof invasive carcinomaandhigh-grade ductal
carcinoma in situ (DCIS) was not as good as low-to-interme-
diate grade DCIS, although the difference was not significant
(P > .1).Discussion
In our study, the d-CAD system was applied directly to
FFDMs, and 96% (71 of 74) of screen-detected malignant
microcalcifications not associated with mass or distortion
were marked. This result is akin to previously reported CAD
sensitivity when using the direct and indirect approach for
detection of malignant microcalcifications (Table 4). Our
results support previous reported sensitivity rates for lesions
with only microcalcifications when compared with other
d-CAD studies [17,20,22]; however, in a study by Kim et al
[22], 55% of carcinomas were described as palpable lesions,
and we selected only nonpalpable lesions. To calculate
this sensitivity of 95.8% (57%e100%), we included all
reviews of the CAD literature and selected lesions that were
only microcalcifications and subsequently proved to be
malignant, which, again, is compatible with the results of our
study. The mean sensitivity reported of all CAD systems,
direct and indirect, for all lesions (masses, architectural
distortions, microcalcifications, and combinations) was 87.2%
(57%e99%).
Various issues may account for variability in the sensi-
tivity of CAD systems. These include mammographic
equipment related factors (difference in technology and
technique), patient-related factors (mammographic lesion
characteristics, lesion histology, and mammographic
density), and software-related factors (brand of software and
specific version of a given brand).
Figure 1. (A) Digital mammogram of a 83-year-old woman with 0.8-cm invasive duct carcinoma not otherwise specified (NOS), estrogen receptor (ER)
positive/progesterone receptor (PR) negative and duct carcinoma in situ surrounding, which were not identified with direct computer-aided detection (CAD).
Mediolateral oblique (right), craniocaudal (center), and mediolateral magnification view (left) demonstrate a 3-mm cluster of faint pleomorphic type
microcalcifications (arrow). (B) Digital mammogram of a 45-year-old woman with 0.25-cm duct carcinoma in situ cribriform nuclear grade 3/3, detected as
9-mm linear branching microcalcifications (arrow) in the lower outer quadrant of the left breast, which were not marked by direct computer-aided detection
(d-CAD). Craniocaudal (right), mediolateral (center), and craniocaudal magnification view (left).
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comparison with screen-film mammography. The issues of
reliability and reproducibility associated with the screen-film
technique are well documented [16,24,25]; these are the
result of the mechanical scanning procedure, and these
virtually do not exist with FFDM as CAD software is directly
applied to the digital mammogram. The need for high spatial
resolution results in a very large file size associated with
a digital mammogram, which, depending on detector area
and pixel size, may reach the size of 50 Mbyte. Such an
image is too large to be displayed at full 1:1 resolution on
current workstations with a monitor resolution of 5-mega-
pixel. Viewing the entire image piece by piece in full reso-
lution may be tedious but essential to ensure that no
microcalcifications are overlooked. Hence, the use of CAD
systems that have superb sensitivity for detection malignant
microcalcifications unassociated with a mass or distortion
seems to be very attractive in digital mammography. Therehas been some discussion about the use of a CAD system as
a prescreening tool, only showing those areas of the image in
full resolution to the radiologist where the CAD system has
marked a lesion [16]. Should CAD demonstrate 100%
sensitivity, this concept has a potential to reduce radiologists’
workloads. However, because the d-CAD system did not
mark 3 of 74 cancers in our study, including a case of high-
grade invasive carcinoma with a DCIS component, such
a concept needs further evaluation.
The impact of mammographic density on CAD detection
has been the subject of several studies [12,15,19,26,27]. All
these studies demonstrated that CAD has better sensitivity for
detection of malignant microcalcifications in dense breasts,
which is concordant with our results. Although none of these
studies reached statistical significance [12,15,19,27], the
combined analysis of all these studies along with our results
demonstrate a statistically significant higher sensitivity for
detection ofmicrocalcifications in dense breast tissue (P¼.03).
Table 4
Summary of lesion characteristics and comparison of CAD performances
Study Y
CAD system
and version
Direct
CAD
Total
no. cancers
Lesion characteristics:
total no. (%) cases
No. (%) cancers
correctly marked
by CAD
No. (%) cancers correctly
marked by CAD seen
as only microcalcification
Present study 2010 Second Look,
version 7.2
Yes 74 Microcalcification, 74 (100) 71 of 74 (96) 71 of 74 (96)
The et al [23] 2009 Second Look,
version 7.2
Yes 123 Microcalcification,
44 (36); masses
with microcalcification,
17 (14); masses, 62 (50)
115 of 123 (94) 41 of 44 (92)
Kim et al [22] 2008 ImageChecker
M1000-DM,
version 3.1
Yes 95 Microcalcification,
34 (33); masses with
microcalcification,
15 (14); masses, 55 (53)
NS 34 of 34 (100)
Yang et al [20] 2007 ImageChecker
M1000-DM,
version 3.1
Yes 103 Microcalcification, 44 (43);
masses with microcalcification,
23 (22); masses, 36 (35)
99 of 103 (96) 44 of 44 (100)
Kim et al [19] 2006 ImageChecker
M1000-DM,
version 3.1
Yes 83 Microcalcification, 24 (29);
masses with microcalcification,
17 (20); masses, 42 (51)
82 of 83 (99) NS of 24
Pai et al [13] 2006 ImageChecker,
version NS
No 58 Microcalcification, 58 (100) 53 of 58 (91) 53 of 58 (91)
Morton et al [4] 2006 ImageChecker
M1000,
version 2.2
No 113 Microcalcification, 31 (27);
masses with microcalcification,
NS; masses, 72 (64);
architectural distortion, 10 (9)
86 of 113 (76) 31 of 31 (100)
Ko et al [6] 2006 Second Look,
version 3
No 48 Microcalcification, 18 (37.5);
masses and asymmetry, 30 (62.5)
45 of 48 (94) 18 of 18 (100)
Soo et al [15] 2005 ImageChecker
M1000,
version 3.2
No 21 Microcalcification, 85 (100) 12 of 21 (57) 12 of 21 (57)
Brem et al [26] 2005 Second Look,
version 3.4
No 201 Microcalcification, 54 (27);
masses with microcalcification,
25 (12); masses, 122 (61)
178 of 201 (89) 53 of 54 (98)
Brem et al [27] 2005 Second Look,
version NS
No 906 Microcalcification,
296 (33); masses, 610 (67)
809 of 906 (95) 280 of 296 (95)
Birdwell et al [3] 2005 ImageChecker,
version 2.2
No 115 Microcalcification, 35 (31);
masses with microcalcification,
24 (21); masses, 54 (48)
88 of 115 (77) 30 of 35 (86)
Malich et al [11] 2003 Second Look,
version NA
No 208 Microcalcification, 58 (28);
masses with microcalcification,
56 (27); masses, 94 (45)
195 of 208 (93.8) NS of 58
Baum et al [17] 2002 ImageChecker
M1000,
version 2.3
Yes 63 Microcalcification, 14 (22);
masses with microcalcification,
12 (19); masses, 37 (59)
52 of 63 (82.5) 14 of 14 (100)
Freer et al [2] 2001 ImageChecker
M1000,
version 2.0
No 49 Microcalcification,
22 (45); masses, 27 (55)
40 of 49 (82) 22 of 22 (100)
Warren Burhenne
et al [1]
2000 ImageChecker
M1000,
version 1.2
No 1083 Microcalcification, 406 (37);
masses, 677 (63)
906 of 1083 (84) 400 of 406 (99)
Total 3343 2831 of 3248 (87.2) 1103 of 1151 (95.8)
CAD ¼ computer-aided detection; NS ¼ not specified.
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rect CAD for malignant masses is lower in dense breast tissue
[15,26,27]. We do not have a valid explanation for the different
effect of breast density on CAD sensitivity in mass lesions vs
calcifications. We presume that this is mainly because the
contrast between microcalcifications and the background is
much higher than between masses and background.
The effect of lesion size on CAD accuracy has been
evaluated in a few studies [12,15,26]. We did not finda significant difference in the d-CAD detection of malignant
microcalcifications as related to lesion size, which is
consistent with previous reports [12,15,26] when using
indirect CAD. Successful d-CAD detection of all malignant
microcalcifications larger than 10 mm in our study needs
further validation before possible future introduction into the
algorithm of management of microcalcifications.
Distribution of microcalcifications is an important crite-
rion in BI-RADS assessment. We did not find a significant
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microcalcifications, alike to previous report by Soo et al [15].
However, subgroups after stratification are small in both
studies, and this limits estimation of CAD accuracy for
different morphologic features of microcalcifications. In the
present study, the suspicious microcalcifications were seen to
be distributed equally between CC and MLO views, and only
patients with nonpalpable microcalcifications seen in FFDM
were included.
A large number of false-positive marks can distract the
interpreting radiologist and decrease the usefulness of CAD.
Therefore, themaximumnumber ofmarks per patient is limited
by the commercial systems. In our study, 1.25 false-positive
markswere observed per patient in normalCCandMLOviews,
and these results were notably lower than the 2.4e5.2 achieved
when using a system that was based on analog images
[1,2,26,27], and also lower than 1.8marks described byYang et
al [20] when using d-CAD. In another recent retrospective
study of CAD with FFDM, The et al [23] found a higher false-
positive rate of 2.3 per patient case. This may be because of
differences of study design, because we counted only square
marks on the screen, specifically for the depiction of micro-
calcifications, and we did not include the circular marks on the
screen, specifically for enhancing masses and architectural
distortion.We assumed that newer CAD software versions tend
to produce fewer false-positive marks per patient.
Our analysis of d-CAD sensitivity separately for CC and
MLO views demonstrated the importance of 2 views for
mammographic interpretation for calcifications. Even though
the d-CAD system did not reveal a statistically significant
difference in the detection of malignant microcalcifications
between MLO and CC views (P ¼ .07), each view provided
additional important yield. The microcalcifications were
marked on both CC and MLO views in 55 of 74 cases (74%),
whereas, in 5 cases (7%), microcalcifications were marked
by the d-CAD system only on MLO, and 11 cases of
malignant microcalcifications (15%) were marked only on
the CC view. We presumed that the difference in technique
(eg, positioning, compression, and motion) may be related to
variation in the detection of microcalcifications by the CAD
system on CC and MLO views.
The specific brand and version of software used may
impact the sensitivity and accuracy of CAD system. One
recent study [28] found that the R2 Technology system was
more accurate than the iCAD system in the detection of
noncalcified masses when mammograms were digitally
scanned by each CAD system. To the best of our knowledge,
no comparison among different CAD systems in the detec-
tion of microcalcifications has been reported in the literature,
and we believe that further research is indeed warranted to
address this issue. A review of the literature that compared
indirect CAD published articles showed the Second Look
(iCAD) sensitivity (mean, 92.95%; 89%e95%) higher than
the Image Checker system (R2 Technology) (mean, 77.83%;
57%e91%) in the detection of malignant lesions (Table 4).
The mean sensitivity of all d-CAD systems, including our
results is 92.46% and the mean sensitivity of the indirectCAD systems is 82.65%. However, if we compare overall
sensitivity for lesions that were calcifications only (not
associated with mass or distortion) similar to our sample, we
found the mean sensitivity of all d-CAD systems, including
our results of 98.29% and the mean sensitivity of the indirect
CAD systems of 91.72%.
Our study had limitations. Because we used a retrospec-
tive design, we included only cases that were referred for
biopsy by a radiologist, and we could not assess the CAD
benefit in the detection of a lesion that may have been
overlooked by a radiologist. Our study group included only
microcalcifications not associated with mass or distortion,
and, as such, we did not assess d-CAD system sensitivity to
all malignant breast lesions, including masses or lesions with
combination of calcifications, mass and or distortion. Despite
these limitations, our study confirmed the high sensitivity of
a d-CAD system in the detection of malignant micro-
calcifications not associated with mass or architectural
distortion. Specificity of CAD however remains limited, and
d-CAD cannot be used independently without interpretation
by a radiologist. The question of whether it might be possible
for the radiologist in the future to improve the workflow of
digital mammography interpretation by avoiding exhaustive
searches of calcifications, but only looking the areas identi-
fied by d-CAD as microcalcifications, remains open.References
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